Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $1.24 Million - $1.54 Million
-9,375 Closed
0 $0
Q4 2021

Feb 09, 2022

SELL
$107.43 - $135.93 $308,861 - $390,798
-2,875 Reduced 23.47%
9,375 $1.27 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $752,780 - $854,518
-7,075 Reduced 36.61%
12,250 $1.32 Million
Q2 2021

Aug 11, 2021

SELL
$105.21 - $117.21 $96,267 - $107,247
-915 Reduced 4.52%
19,325 $2.18 Million
Q1 2021

May 11, 2021

SELL
$102.3 - $112.62 $333,498 - $367,141
-3,260 Reduced 13.87%
20,240 $2.19 Million
Q4 2020

Feb 10, 2021

BUY
$80.49 - $108.67 $160,980 - $217,340
2,000 Added 9.3%
23,500 $2.52 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $2.24 Million - $2.63 Million
-26,125 Reduced 54.86%
21,500 $1.88 Million
Q2 2020

Aug 13, 2020

SELL
$73.37 - $98.18 $559,446 - $748,622
-7,625 Reduced 13.8%
47,625 $4.68 Million
Q1 2020

May 12, 2020

BUY
$64.5 - $97.79 $3.31 Million - $5.01 Million
51,250 Added 1281.25%
55,250 $4.21 Million
Q4 2019

Feb 11, 2020

SELL
$72.13 - $90.25 $216,390 - $270,750
-3,000 Reduced 42.86%
4,000 $354,000
Q3 2019

Oct 31, 2019

BUY
$62.98 - $75.72 $47,235 - $56,790
750 Added 12.0%
7,000 $530,000
Q2 2019

Aug 05, 2019

BUY
$65.7 - $83.98 $410,625 - $524,875
6,250 New
6,250 $455,000
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $302,294 - $336,056
-3,400 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $8,978 - $10,623
-100 Reduced 2.86%
3,400 $315,000
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $36,804 - $49,284
-400 Reduced 10.26%
3,500 $331,000
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $349,284 - $383,019
3,900
3,900 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $293B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Game Creek Capital, LP Portfolio

Follow Game Creek Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Game Creek Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Game Creek Capital, LP with notifications on news.